GLP-1 Stomach Paralysis Lawsuits The new GLP-1 pulmonary aspiration warnings come as the manufacturers already face hundreds of Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits, each raising similar allegations that users and the medical community were not adequately warned about serious risks that may result from delayed gastric emptying caused by the medications
Referencias bibliogrficas Askarpour, M., Hadi, A., Miraghajani, M., Symonds, M
Journal of the ASEAN Federation of Endocrine Societies, 37 (2), 65-72
Jul 16, 2026 FDA Publishes All 7 Briefing Documents Ahead of the July 2026 PCAC Meeting The FDA has posted all seven scientific briefing documents for the July 2324, 2026 Pharmacy Compounding Advisory Committee meeting an unusually clear window into the agency's current thinking on peptide safety, efficacy, and characterization
Biochem Biophys Res Commun (2021) 576:339
Front Med (lausanne) 7:256